Back
Titan Machinery 10K Form
Sell
40
TITN
Titan Machinery
Last Price:
$13.81
Seasonality Move:
4.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-07 | 10Q | TITN/Titan Machinery Quarterly |
2023-12-07 | 10Q | TITN/Titan Machinery Quarterly |
2023-09-07 | 10Q | TITN/Titan Machinery Quarterly |
2023-06-01 | 10Q | TITN/Titan Machinery Quarterly |
2022-12-08 | 10Q | TITN/Titan Machinery Quarterly |
2022-09-09 | 10Q | TITN/Titan Machinery Quarterly |
Receive TITN News And Ratings
See the #1 stock for the next 7 days that we like better than TITN
TITN Financial Statistics
Sales & Book Value
Annual Sales: | $2.8B |
---|---|
Cash Flow: | $-17.1M |
Price / Cash Flow: | 0 |
Annual Sales: | $28.89 |
Price / Book: | 0.48 |
Profitability
EPS (TTM): | 1.33880 |
---|---|
Net Income (TTM): | $30.8M |
Gross Margin: | $531.4M |
Return on Equity: | 4.71% |
Return on Assets: | 1.53% |
Titan Machinery Earnings Forecast
Key Titan Machinery Financial Ratios
-
The Gross Profit Margin over the past 22 years for TITN is 19.26%.
-
The Selling, General & Administrative Expenses for TITN have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 18.77% of Operating Income.
-
The Net Earning history of TITN is 4.08% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 15 years.
Titan Machinery Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Trading Companies & Distributors |
Sector: | Industrials |
Current Symbol: | TITN |
CUSIP: | 88830R |
Website: | titanmachinery.com |
Debt
Debt-to-Equity Ratio: | 1.78 |
---|---|
Current Ratio: | 1.32 |
Quick Ratio: | 0.14 |
Price-to-Earnings
Trailing P/E Ratio: | 2.8 |
---|---|
Forward P/E Ratio: | 0 |
TITN Technical Analysis vs Fundamental Analysis
Sell
40
Titan Machinery (TITN)
is a Sell
Is Titan Machinery a Buy or a Sell?
-
Titan Machinery stock is rated a SellThe current Titan Machinery [TITN] share price is $13.82. The Score for TITN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.